Van Dang

WORK HISTORY

EDUCATION

SKILLS

ABOUT VAN DANG

As Scientific Director of the Ludwig Institute for Cancer Research in New York, Chi Van Dang shapes scientific strategy and leads oversight of operations of its Lausanne, Oxford, Princeton and San Diego Branches. He also catalyzes interactions among 6 Ludwig research centers at Chicago, Harvard, Hopkins, MIT, MSKCC, and Stanford. Chi’s Ludwig Laboratory is housed at Johns Hopkins University School of Medicine, where he is Bloomberg Distinguished Professor of Cancer Medicine, Professor of Oncology, Professor of Cell Biology, and Professor of Biochemistry & Molecular Biology in the Johns Hopkins Bloomberg School of Public Health. Prior to Ludwig, Dang served as Director of the Abramson Cancer Center of the University of Pennsylvania and Professor of Medicine in 2011. As Director, he launched a series of Translational Centers of Excellence, which propels teams of scientists, nurses, and clinicians to reach for the cure for various cancers. At Johns Hopkins, he was the Johns Hopkins Family Professor in Oncology Research, Vice Dean for Research of the School of Medicine, director of the Institute for Cell Engineering, and Professor of Medicine, Pathology, Oncology, and Cell Biology with joint appointment in Molecular Biology and Genetics.Dr. Dang serves on numerous editorial boards and has authored over 200 scientific and medical articles, book chapters and books. He is a member or fellow of the National Academy of Medicine, American Academy of Arts & Sciences, American Association for Cancer Research Academy, American Society for Clinical Investigation (ASCI) and The Association of American Physicians. He was president of the ASCI (2003). He served on the US Cancer Moonshot Blue Ribbon Panel and chaired the National Cancer Institute Board of Scientific Advisors. He is chief science advisor for the Gray Foundation. He sponsored and mentored many NIH K08 physician-scientist awardees, Ph.D. doctorates and post-doctoral fellows. The Dang lab has contributed to the understanding of the function of the MYC oncogene. His laboratory established the first mechanistic link between the MYC cancer gene and cellular energy metabolism, contributing to the concept that genetic alterations in cancers re-program fuel utilization by tumors and render cancers addicted to certain fuel sources.